The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Dopamine-Mediated Autocrine Inhibitory Circuit Regulating Human Insulin Secretion in Vitro
Abstract
We describe a negative feedback autocrine regulatory circuit for glucose-stimulated insulin secretion in purified human islets in vitro. Using chronoamperometry and in vitro glucose-stimulated insulin secretion measurements, evidence is provided that dopamine (DA), which is loaded into insulin-containing secretory granules by vesicular monoamine transporter type 2 in human β-cells, is released in response to glucose stimulation. DA then acts as a negative regulator of insulin secretion via its action on D2R, which are also expressed on β-cells. We found that antagonism of receptors participating in islet DA signaling generally drive increased glucose-stimulated insulin secretion. These in vitro observations may represent correlates of the in vivo metabolic changes associated with the use of atypical antipsychotics, such as increased adiposity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Substantial Production of Dopamine in the Human Gastrointestinal Tract
Eisenhofer, G., Åneman, A., Friberg, P., Hooper, D., Fåndriks, L., Lonroth, H., Hunyady, B., & Mezey, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4339 · Cited by 394
Innervation Patterns of Autonomic Axons in the Human Endocrine Pancreas
Rodriguez-Diaz, R., Abdulreda, M. H., Formoso, A. L., Gans, I., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.05.008 · Cited by 356
The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier
Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02758-x · Cited by 298
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225 · cited 1×
“Thus, ATA via antagonism at D2R and 5-HT receptors could potentially promote -cell loss by allowing -cells to produce more insulin (63, 64) with resultant endoplasmic reticulum stress (65).”
BackgroundA fluorimetric and amperometric study of calcium and secretion in isolated mouse pancreatic ?-cells
Smith, P. A., Duchen, M. R., & Ashcroft, F. M. (1995) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00386180 · Cited by 80
Research works printed but not linked: 62
- Brunicardi, 1995, Neural regulation of the endocrine pancreas., Int J Pancreatol, 18, 177, 10.1007/BF02784941 · DOI
- Ahrén, 2000, Autonomic regulation of islet hormone secretion–implications for health and disease., Diabetologia, 43, 393, 10.1007/s001250051322 · DOI · Paper page
- Cabrera, 2006, The unique cytoarchitecture of human pancreatic islets has implications for islet cell function., Proc Natl Acad Sci USA, 103, 2334, 10.1073/pnas.0510790103 · DOI · Paper page
- Rodriguez-Diaz, 2011, α-Cells secrete acetylcholine as a non-neuronal paracrine signal priming β-cell function in humans., Nat Med, 17, 888, 10.1038/nm.2371 · DOI · Paper page
- Wolf, 1987, Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors., Neuropharmacology, 26, 1053, 10.1016/0028-3908(87)90248-6 · DOI
- Westerink, 1989, On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals., Neurosci Lett, 99, 197, 10.1016/0304-3940(89)90289-9 · DOI
- Maffei, 2004, Identification of tissue-restricted transcripts in human islets., Endocrinology, 145, 4513, 10.1210/en.2004-0691 · DOI
- Kutlu, 2009, Detailed transcriptome atlas of the pancreatic β-cell., BMC Med Genomics, 2, 3, 10.1186/1755-8794-2-3 · DOI
- Anlauf, 2003, Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors., J Histochem Cytochem, 51, 1027, 10.1177/002215540305100806 · doi:10.1177/002215540305100806
- Henry, 1994, Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules., J Exp Biol, 196, 251, 10.1242/jeb.196.1.251 · DOI
- Rubí, 2005, Dopamine D2-like receptors are expressed in pancreatic β-cells and mediate inhibition of insulin secretion., J Biol Chem, 280, 36824, 10.1074/jbc.M505560200 · DOI · Paper page
- Ericson, 1977, Accumulation of dopamine in mouse pancreatic B-cells following injection of l-DOPA. Localization to secretory granules and inhibition of insulin secretion., Diabetologia, 13, 117, 10.1007/BF00745138 · DOI
- Saisho, 2008, Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas., J Mol Histol, 39, 543, 10.1007/s10735-008-9195-9 · DOI
- Schmittgen, 2008, Analyzing real-time PCR data by the comparative CT method., Nat Protoc, 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
- Weksler-Zangen, 2001, The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences., Diabetes, 50, 2521, 10.2337/diabetes.50.11.2521 · DOI
- Pennington, 2004, Simultaneous real-time amperometric measurement of catecholamines and serotonin at carbon fibre ‘dident’ microelectrodes., J Neurosci Methods, 140, 5, 10.1016/j.jneumeth.2004.03.023 · DOI
- Gonon, 1981, Electrochemical treatment of pyrolytic carbon fiber electrodes., Anal Chem, 53, 1386, 10.1021/ac00232a020 · DOI · Paper page
- Michael, 1987, Oxidation of dopamine and 4-methylcatechol at carbon fiber disk electrodes., Anal Chem, 59, 405, 10.1021/ac00130a006 · doi:10.1021/ac00130a006
- Ahn, 1991, Biphasic striatal dopamine release during transient ischemia and reperfusion in gerbils., Stroke, 22, 674, 10.1161/01.STR.22.5.674 · doi:10.1161/01.str.22.5.674
- Crespi, 1983, Differential pulse voltammetry in brain tissue. III. Mapping of the rat serotoninergic raphe nuclei by electrochemical detection of 5-HIAA., Brain Res, 270, 45, 10.1016/0006-8993(83)90790-4 · doi:10.1016/0006-8993(83)90790-4
- Veldhuis, 1986, Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection., Am J Physiol, 250, E486
- Tan, 2003, Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter., Int Rev Neurobiol, 54, 145, 10.1016/S0074-7742(03)54005-3 · DOI
- Raffo, 2008, Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine., J Endocrinol, 198, 41, 10.1677/JOE-07-0632 · DOI
- Leysen, 1989, Ketanserin reduces a particular monoamine pool in peripheral tissues., Mol Pharmacol, 35, 375, 10.1016/S0026-895X(25)11126-7 · doi:10.1016/s0026-895x(25)11126-7
- Reches, 1983, Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of α methyl-p-tyrosine., Life Sci, 33, 157, 10.1016/0024-3205(83)90408-3 · doi:10.1016/0024-3205(83)90408-3
- Kühtreiber, 2010, Islet isolation from human pancreas with extended cold ischemia time., Transplant Proc, 42, 2027, 10.1016/j.transproceed.2010.05.099 · doi:10.1016/j.transproceed.2010.05.099
- Shankar, 2006, Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro., IUBMB Life, 58, 157, 10.1080/15216540600687993 · DOI
- Kristensen, 2011, SLC6 neurotransmitter transporters: structure, function, and regulation., Pharmacol Rev, 63, 585, 10.1124/pr.108.000869 · DOI · Paper page
- Giros, 1996, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter., Nature, 379, 606, 10.1038/379606a0 · DOI · Paper page
- Hellman, 2009, Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets., Endocrinology, 150, 5334, 10.1210/en.2009-0600 · DOI
- Song, 2002, Pulsatile insulin secretion by human pancreatic islets., J Clin Endocrinol Metab, 87, 213, 10.1210/jcem.87.1.8181 · DOI
- Crespi, 1990, In vivo voltammetry with micro-biosensors for analysis of neurotransmitter release and metabolism., J Neurosci Methods, 34, 53, 10.1016/0165-0270(90)90042-E · DOI
- Aspinwall, 1999, Comparison of amperometric methods for detection of exocytosis from single pancreatic β-cells of different species., Anal Chem, 71, 5551, 10.1021/ac990817e · DOI
- Barbosa, 1998, Control of pulsatile 5-HT/insulin secretion from single mouse pancreatic islets by intracellular calcium dynamics., J Physiol, 510, 135, 10.1111/j.1469-7793.1998.135bz.x · DOI
- Matecka, 1996, Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy] ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)., J Med Chem, 39, 4704, 10.1021/jm960305h · DOI
- He, 1993, Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites., J Med Chem, 36, 4075, 10.1021/jm00077a011 · doi:10.1021/jm00077a011
- Thorens, 2010, Central control of glucose homeostasis: the brain-endocrine pancreas axis., Diabetes Metab, 36, S45, 10.1016/S1262-3636(10)70466-3 · DOI
- Falck, 1964, A fluorescent reaction for monoamines in the insulin producing cells of the guinea-pig., Acta Endocrinol (Copenh), 45, 133, 10.1530/acta.0.0450133 · DOI
- Cegrell, 1967, Dopamine and 5-hydroxytryptamine in the guinea-pig pancreas., Life Sci, 6, 2483, 10.1016/0024-3205(67)90311-6 · doi:10.1016/0024-3205(67)90311-6
- Jaim-Etcheverry, 1968, Electron microscopic cytochemistry of 5-hydroxytryptamine (5-HT) in the β-cells of guinea pig endocrine pancreas., Endocrinology, 83, 917, 10.1210/endo-83-5-917 · DOI
- Zawalich, 2001, Are 5-hydroxytryptamine-preloaded β-cells an appropriate physiologic model system for establishing that insulin stimulates insulin secretion?, J Biol Chem, 276, 37120, 10.1074/jbc.M105008200 · DOI
- Ito, 1995, Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas., Diabetologia, 38, 1276, 10.1007/BF00401759 · DOI
- Iturriza, 1993, Immunohistochemical investigation of tyrosine-hydroxylase in the islets of Langerhans of adult mice, rats and guinea pigs., Neuroendocrinology, 57, 476, 10.1159/000126394 · doi:10.1159/000126394
- Mezey, 1996, A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine., Proc Natl Acad Sci USA, 93, 10377, 10.1073/pnas.93.19.10377 · DOI
- Bannon, 2005, The dopamine transporter: role in neurotoxicity and human disease., Toxicol Appl Pharmacol, 204, 355, 10.1016/j.taap.2004.08.013 · DOI
- Boado, 1999, Selective expression of the large neutral amino acid transporter at the blood-brain barrier., Proc Natl Acad Sci USA, 96, 12079, 10.1073/pnas.96.21.12079 · DOI · Paper page
- Goldstein, 1999, Sources and physiological significance of plasma dopamine sulfate., J Clin Endocrinol Metab, 84, 2523, 10.1210/jcem.84.7.5864 · DOI · Paper page
- Hansen, 2004, Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders., Current medicinal chemistry, 11, 1595, 10.2174/0929867043365026 · DOI
- Aston-Mourney, 2008, Too much of a good thing: why it is bad to stimulate the β-cell to secrete insulin., Diabetologia, 51, 540, 10.1007/s00125-008-0930-2 · DOI
- Nord, 2011, Antipsychotic occupancy of dopamine receptors in schizophrenia., CNS Neurosci Ther, 17, 97, 10.1111/j.1755-5949.2010.00222.x · DOI · Paper page
- Elias, 2008, Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications., Am J Med, 121, 98, 10.1016/j.amjmed.2007.08.036 · DOI
- Holt, 2006, Antipsychotic drugs and diabetes: an application of the Austin Bradford Hill criteria., Diabetologia, 49, 1467, 10.1007/s00125-006-0279-3 · DOI
- Johnson, 2005, Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia., Diabetes, 54, 1552, 10.2337/diabetes.54.5.1552 · DOI
- Melkersson, 2004, Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro., Eur Neuropsychopharmacol, 14, 115, 10.1016/S0924-977X(03)00072-5 · DOI
- Melkersson, 2001, Different effects of antipsychotic drugs on insulin release in vitro., Eur Neuropsychopharmacol, 11, 327, 10.1016/S0924-977X(01)00108-0 · DOI
- Lindström, 1983, Opposite effects of 5-hydroxytryptophan and 5-hydroxytryptamine on the function of microdissected ob/ob-mouse pancreatic islets., Diabetologia, 24, 52, 10.1007/BF00275948 · DOI
- Grill, 2009, Impact of metabolic abnormalities for β-cell function: clinical significance and underlying mechanisms., Mol Cell Endocrinol, 297, 86, 10.1016/j.mce.2008.06.009 · DOI
- Qian, 2008, Endoplasmic reticulum stress in β-cells: latent mechanism of secondary sulfonylurea failure in type 2 diabetes?, Med Hypotheses, 71, 889, 10.1016/j.mehy.2008.07.031 · DOI
- Meier, 1992, Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics., Experientia, 48, 248, 10.1007/BF01930467 · DOI
- Kirchgessner, 1990, Innervation of the pancreas by neurons in the gut., J Neurosci, 10, 1626, 10.1523/JNEUROSCI.10-05-01626.1990 · DOI · Paper page
- Rubino, 2010, Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus., Nature reviews Endocrinology, 6, 102, 10.1038/nrendo.2009.268 · DOI · Paper page
- DiGiorgi, 2010, Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up., Surg Obes Relat Dis, 6, 249, 10.1016/j.soard.2009.09.019 · DOI · Paper page
Cited by
Dopamine-mediated autocrine inhibition of insulin secretion
Ferrero, E., Masini, M., Carli, M., Moscato, S., Beffy, P., Vaglini, F., Mattii, L., Corti, A., Scarselli, M., Novelli, M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112294 · Cited by 4
“Simpson et al. (2012) also demonstrated that D 2 receptor antagonists haloperidol and sulpiride increase insulin secretion in isolated pancreatic islets.”
Influential
Metadata
- Authors
- Simpson, N., Maffei, A., Freeby, M., Burroughs, S., Freyberg, Z., Javitch, J., Leibel, R. L., & Harris, P. E.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2012-10-01
- Volume
- 26
- Issue
- 10
- Pages
- 1757-1772
- ISSN
- 0888-8809
- 1944-9917
- Cited by
- 86
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.